DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,617 | +2.1% | 6,516 | -1.3% | 0.08% | +5.3% |
| Q2 2023 | $1,584 | +22.2% | 6,600 | +28.3% | 0.08% | +16.9% |
| Q1 2023 | $1,296 | -10.9% | 5,143 | -6.1% | 0.06% | -18.8% |
| Q4 2022 | $1,454 | -99.9% | 5,477 | -2.2% | 0.08% | -1.2% |
| Q3 2022 | $1,446,000 | +16.9% | 5,599 | +14.7% | 0.08% | +20.9% |
| Q2 2022 | $1,237,000 | -20.6% | 4,881 | -8.1% | 0.07% | -5.6% |
| Q1 2022 | $1,558,000 | -13.0% | 5,310 | -2.4% | 0.07% | -7.8% |
| Q4 2021 | $1,790,000 | +9.1% | 5,442 | +1.0% | 0.08% | -1.3% |
| Q3 2021 | $1,641,000 | +2.4% | 5,389 | -9.7% | 0.08% | +2.6% |
| Q2 2021 | $1,602,000 | +17.4% | 5,968 | -1.5% | 0.08% | 0.0% |
| Q1 2021 | $1,364,000 | +7.2% | 6,060 | +5.8% | 0.08% | -32.1% |
| Q4 2020 | $1,272,000 | -52.4% | 5,726 | -53.8% | 0.11% | -56.2% |
| Q3 2020 | $2,670,000 | +6.6% | 12,401 | -12.4% | 0.26% | +8.0% |
| Q2 2020 | $2,505,000 | +27.5% | 14,164 | -0.2% | 0.24% | +1.3% |
| Q1 2020 | $1,964,000 | -11.0% | 14,189 | -1.3% | 0.23% | +19.4% |
| Q4 2019 | $2,206,000 | -1.0% | 14,373 | -6.8% | 0.20% | -10.1% |
| Q3 2019 | $2,228,000 | +1.7% | 15,429 | +0.7% | 0.22% | -0.9% |
| Q2 2019 | $2,191,000 | +3.4% | 15,329 | -4.5% | 0.22% | -3.5% |
| Q1 2019 | $2,119,000 | +25.7% | 16,052 | -1.8% | 0.23% | +6.0% |
| Q4 2018 | $1,686,000 | -4.0% | 16,353 | +1.1% | 0.22% | +8.0% |
| Q3 2018 | $1,757,000 | +10.8% | 16,170 | +0.6% | 0.20% | +1.0% |
| Q2 2018 | $1,586,000 | +9.5% | 16,075 | +8.7% | 0.20% | +4.2% |
| Q1 2018 | $1,448,000 | -21.9% | 14,794 | -25.9% | 0.19% | -16.4% |
| Q4 2017 | $1,853,000 | +1.1% | 19,967 | -6.6% | 0.23% | -5.0% |
| Q3 2017 | $1,833,000 | +43.7% | 21,372 | +41.3% | 0.24% | +43.4% |
| Q2 2017 | $1,276,000 | -3.3% | 15,124 | -2.0% | 0.17% | -7.3% |
| Q1 2017 | $1,319,000 | -13.2% | 15,425 | -20.9% | 0.18% | -20.1% |
| Q4 2016 | $1,519,000 | +2.5% | 19,509 | +3.2% | 0.22% | +1.4% |
| Q3 2016 | $1,482,000 | -22.4% | 18,907 | -0.1% | 0.22% | -29.4% |
| Q2 2016 | $1,911,000 | +7.7% | 18,926 | +1.2% | 0.31% | +1.6% |
| Q1 2016 | $1,774,000 | +14.9% | 18,696 | +12.5% | 0.31% | +10.4% |
| Q4 2015 | $1,544,000 | +9.5% | 16,626 | +0.5% | 0.28% | -1.4% |
| Q3 2015 | $1,410,000 | +28.6% | 16,548 | +29.2% | 0.28% | +40.1% |
| Q2 2015 | $1,096,000 | +1.5% | 12,809 | +0.7% | 0.20% | +10.4% |
| Q1 2015 | $1,080,000 | +0.4% | 12,718 | +1.3% | 0.18% | +10.9% |
| Q4 2014 | $1,076,000 | +12.8% | 12,550 | 0.0% | 0.16% | +10.7% |
| Q3 2014 | $954,000 | -3.0% | 12,550 | +0.4% | 0.15% | -5.1% |
| Q2 2014 | $984,000 | +4.9% | 12,500 | 0.0% | 0.16% | -4.3% |
| Q1 2014 | $938,000 | -4.2% | 12,500 | -1.4% | 0.16% | -29.0% |
| Q4 2013 | $979,000 | +11.4% | 12,680 | 0.0% | 0.23% | -0.4% |
| Q3 2013 | $879,000 | +11.1% | 12,680 | +1.4% | 0.23% | +6.9% |
| Q2 2013 | $791,000 | – | 12,500 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |